Abstract
A case is reported of idiopathic relapsed autoimmune hemolytic anemia successfully treated with rituximab. A 43-year-old white male patient with past medical history of Evans syndrome was found to have recurrent autoimmune hemolytic anemia. Previous treatments included steroids, splenectomy, intravenous immunoglobulin, plasmapheresis, staphylococcal Protein A immunoadsorption (Prosorba column), and chemotherapeutic agents (cytoxan and vincristine). Rituximab was given weekly at 375 mg/m2 for 4 doses. The drug was well tolerated and the patient remains in remission 9 months after completion of therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 335-336 |
Number of pages | 2 |
Journal | International journal of hematology |
Volume | 78 |
Issue number | 4 |
DOIs | |
State | Published - Nov 2003 |
Externally published | Yes |
Keywords
- Immune hemolytic anemia
- Rituximab
ASJC Scopus subject areas
- Hematology